ForSight Labs

K. Angela Macfarlane
President & CEO

Ms. Macfarlane joined ForSight Labs as President and CEO in March of 2007. Ms. Macfarlane brings broad experience in early stage company formation to ForSight Labs with the goal of creating a community where innovation, creative solutions and “the doing” are combined to build value and create companies focused on improving the lives of visually impaired patients. 

From 2005 to 2007, prior to joining the ForSight Labs team full-time, Ms. Macfarlane served as Chief Technology Counsel to The Foundry and participated on the ForSight Labs senior management team through her role at The Foundry, as well as working with early stage Foundry start ups. From 1999 through 2004, Ms. Macfarlane served as Technology Counsel for Thomas J. Fogarty, M.D., a renowned physician/entrepreneur, where she participated in all aspects of early stage technology review, licensing, intellectual property management and company creation. Previously, Ms. Macfarlane served as part of the senior management team and in-house counsel at several medical device start-up companies, including TransVascular, Inc. (acquired by Medtronic), AneuRx, Inc. (acquired by Medtronic), and VidaMed Inc. (through IPO).

Ms. Macfarlane participates on the board of the ForSight VISION companies. She is an inventor on three U.S. issued patents with others currently pending. Ms. Macfarlane received her BA in Business Administration from San Francisco State University, and her J.D. from Golden Gate University School of Law.